Rotavirus Vaccine

Ramsha Ansari
MBBS, Medical Editorial Team, Pediatric Oncall.
First Author
Jagdish Kathwate
MD Pediatrics.
Assistant Professor, Government Medical College, Aurangabad, India.

First Created: 01/10/2007  Last Updated: 12/27/2023

Patient Education

What is Rotavirus?

Rotavirus gets its name from the fact that, under a microscope, the virus resembles a wheel. This nasty, potentially lethal bug causes severe acute gastroenteritis with diarrhea and vomiting, primarily in infants and young children. Fortunately, there are 4 types of rotavirus vaccines that can protect children from this disease.

How Big a Problem Is Rotavirus Infection?

Worldwide, it is the leading cause of severe diarrhea among young children, leading to 2 million hospitalizations and more than 500,000 deaths of children ages 5 and under annually. Older children and adults can also be infected with the virus, but the illness is generally milder. Rotavirus disease is highly contagious. The germ is present in the stool of an infected person and can remain viable for a long time on contaminated surfaces, including people's hands. Children catch it by touching something that's contaminated and then putting their hands in their mouths. The spread of rotavirus infection is a particular problem in hospitals and in daycare settings, where it can be easily spread from child to child. It's also easily spread by daycare workers, especially when they change diapers without washing their hands afterward.

What are Symptoms of rotavirus infection?

Symptoms of rotavirus infection may last up to eight days, include fever, nausea, vomiting, abdominal cramps, and frequent, watery diarrhea. If it's severe enough, diarrhea can cause dehydration, and it's the dehydration that's responsible for the hospitalizations and deaths associated with this disease.

How Is the Rotavirus Vaccine Given?

There are four brands of rotavirus vaccines are available in India namely RV-1 [Rotarix], RV-5 [RotaTeq], RV-116E [Rotavac] and Rotasil. All the 4 vaccines are given orally. The minimum age they can be given is 6 weeks.

RV-5 [RotaTeq], RV-116E [Rotavac] and Rotasil are administered in a 3-dose schedule at 6-10-14 weeks.

RV-1 [Rotarix] is administered in 2 doses by mouth at 6-10 weeks and the second dose atleast 4 weeks apart.

The vaccine may be given at the same time as other vaccines, and the Indian Academy of Pediatrics recommends that the rotavirus vaccine be included as part of the routine immunizations given to infants.

India has developed its first vaccine Rotavac under the public-private partnership. The indigenous low-cost vaccine, to prevent rotavirus diarrhea that claims the lives of about 1 lakh children a year, will soon hit the market. Priced at around Rs 54 ($1), it will be a boon for developing countries that are fighting the killer virus.

How Effective Is the Rotavirus Vaccine?

Studies of the rotavirus vaccine have shown that it can prevent about 74% of rotavirus infections. More importantly, it can prevent approximately 98% of severe infections and 96% of hospitalizations from rotavirus.

What are the side effects and Contraindications?

Both rotavirus vaccines are safe and well-tolerated with occasional vomiting, diarrhea. Intussusception incidence is not increased but caution is recommended in children with uncorrected congenital malformation of the GI tract which predisposes to intussusception.

The vaccine is contraindicated in an infant who has a history of severe allergy (e.g. anaphylaxis) to the rotavirus vaccine previously. Human monovalent vaccine oral applicator contains latex hence this is contraindicated in an infant with severe latex allergy.

The vaccines should not be given in children with a history of previous intussusceptions or immunodeficiency.

What should be done if a child spits the vaccine?

Administration of vaccine is not required if the infant spits, vomits or regurgitates during or after administration of the vaccine though manufacturers of human monovalent vaccine recommend the dose may be repeated at the same visit. The infant should receive the remaining recommended doses as per the routine schedule.

1. Parashar UD, Hummelman EG, Bresse JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Em Infect Dis, 2003; 9:565-571.
2. UNICEF. 2008 State of the World's Children Report. http:// www. unicef. Org/ sowc08/ full report /full_report.php. Accessed on 25th December 2009.
3. Burden of diarrhea in india estimation of burden of diarrheal disease in india. National Institute of cholera and enteric diseases Kolkata.
4. Yewale V, Choudhury P, Thacker N. IAP guidebook on immunization year 2009-2011. Indian Academy of Pediatrics. Mumbai. 2011.
5. Shah NK. Rotavirus vaccine - What are the concerns of the developing countries? Journal of Pediatric Sciences. 2010; 5: e50.
6. Yachha SK, Singh. V, Kanwar S ,Mehta S. Epidemiology , subgroups and serotypes of Rotavirus diarrhea in north Indian communities. Indian pediatric 1994; 31:27-33.
7. Zaman K, Sack DA, Yunus M, et al. Immunogenicity of an oral polio vaccine is unaffected when co-administered with a human rotavirus vaccine in Bangladeshi children. Proc 5th World Congr Pediatr Infect Dis (WSPID) 2007.
8. Schuster V, Vesikari T, Karvonen A et al. Breastfeeding does not influence the efficacy of RotarixTM. Paper presented at 25th International Congress of Pediatrics (ICP) 2007, Athens, Greece PP0990.
9. Peres-Sachel I, Salinas B, Tomat M, et al. Efficacy of Human Rotavirus Vaccine RIX4414 in malnourished children. J Infect Dis 2007;196:537-40.
10. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC et al. Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis. N Engl J Med 2006; 354:11-22.
11. Linhares AC, Velazquez FR, Pérez-Schael I, Llorens XS, Abate H, Espinoza S et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomized, double blind, placebo controlled phase III study. Lancet, 2008; 371:1181-1189.
12. Vesikari T, Matson D, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33.
13. Velazquez, F.R., et al., Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis, 2000. 182(6): 1602-1609.
14. O'Neal, C.M., G.R. Harriman, and M.E. Conner, Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A. J Virol, 2000. 74(9): 4102-4109.
14. [Internet] IAP Vaccine Information. ACVIP: 2020-2021 Available from:
15. (Internet) Rotavirus (RV) Vaccine Advisory Committee on Vaccines & Immunization Practices. Available from:

Rotavirus Vaccine Rotavirus Vaccine 2023-12-27
Disclaimer: The information given by is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0